HIKMA INTL PHARMS FDA Approval ANDA 040667

ANDA 040667

HIKMA INTL PHARMS

FDA Drug Application

Application #040667

Application Sponsors

ANDA 040667HIKMA INTL PHARMS

Marketing Status

Discontinued001
Prescription002

Application Products

001TABLET;ORAL50MG0PRIMIDONEPRIMIDONE
002TABLET;ORAL250MG0PRIMIDONEPRIMIDONE

FDA Submissions

ORIG1AP2006-07-27
LABELING; LabelingSUPPL2AP2010-05-20
LABELING; LabelingSUPPL4AP2011-11-29

Submissions Property Types

SUPPL2Null7
SUPPL4Null15

TE Codes

002PrescriptionAB

CDER Filings

HIKMA INTL PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 40667
            [companyName] => HIKMA INTL PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"PRIMIDONE","activeIngredients":"PRIMIDONE","strength":"50MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"PRIMIDONE","activeIngredients":"PRIMIDONE","strength":"250MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"PRIMIDONE","submission":"PRIMIDONE","actionType":"50MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"PRIMIDONE","submission":"PRIMIDONE","actionType":"250MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.